A

Apellis Pharma (APLS)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Apellis Pharma (APLS)

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more

Open
USD17.43
High
USD17.60
Low
USD17.15
52 Week High
USD42.47
Monthly Return
3.20%
Revenue
776M

Daily Vol.
2.24M
Avg. Daily Vol.
2.25M
Market Cap.
2.2B
52 Week Low
16.10
Annual Return
-58.00%

Stock News

Meta’s stock hits a record high as Mark Zuckerberg goes on an AI hiring spree

Meta’s stock hits a record high as Mark Zuckerberg goes on an AI hiring spree

MarketWatch

25-year-old skipped college—now her company brings in more than $1 million a week on Whatnot

25-year-old skipped college—now her company brings in more than $1 million a week on Whatnot

CNBC

QXO turns attention elsewhere as Home Depot nabs GMS - source

QXO turns attention elsewhere as Home Depot nabs GMS - source

Yahoo

Market lessons from the first half of 2025 — and, stocks that look good going forward

Market lessons from the first half of 2025 — and, stocks that look good going forward

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.